Catalyst Wire Dossier Catalyst Wire Dossier

Ethosuximide

ethosuximide · PAI Holdings, LLC dba PAI Pharma
Drug timelines are a Plus or Pro feature.

25 regulatory and trial events tracked for Ethosuximide, covering 2008-03-03 to 2026-04-21. Get the full timeline:

Most recent: Clinical Trial Update: Assessment of the Effectiveness of Ethosuximide in the Treatment of Peripheral Neuropathic Pain. [Phase 2]

See pricing